0132-0215 : Phazyme 250 mg Oral Capsule, Gelatin Coated


NDC: 0132-0215
Labeler: C.b. Fleet Company, Inc.
Product Type: Human OTC Drug
Drug Name:  Phazyme
Dosage Form: Oral Capsule, Gelatin Coated
Application #: part332
Rev. Date: 


Appearance:


Markings: PZ;250
Shapes:  Capsule
Colors:  Purple
Size (mm): 11
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0132-0215-37: 1 BLISTER PACK IN 1 BOX (0132‑0215‑37) > 36 CAPSULE, GELATIN COATED IN 1 BLISTER PACK

Active Ingredients:

  • Dimethicone

Dosage Strength:

  • 250 mg

Related Products:

Based on records with the same trade name.
  • 0132-0208 Phazyme Ultra 180 mg Oral Capsule by C.b. Fleet Company, Inc.
  • 0132-0211 Phazyme 250 mg Oral Capsule, Gelatin Coated by C.b. Fleet Company, Inc.
  • 0132-0214 Phazyme 250 mg Oral Capsule, Gelatin Coated by C.b. Fleet Company, Inc.
  • 0132-0507 Phazyme Oral Tablet, Chewable by C.b. Fleet Company, Inc.
  • 0135-0429 Phazyme Ultra 180 mg Oral Capsule by Glaxosmithkline Consumer Healthcare Lp
  • 63029-550 Phazyme Ultra 180 mg Oral Capsule by Medtech Products Inc.
  • 68788-0758 Phazyme 180 mg Oral Capsule, Gelatin Coated by Preferred Pharmaceuticals, Inc.
  • 68788-9070 Phazyme Ultra 180 mg Oral Capsule by Preferred Pharmaceuticals, Inc
  • 68788-9224 Phazyme 180 mg Oral Capsule, Gelatin Coated by Preferred Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0132-0215 QR Code

< Prev: 0132-0214Next: 0132-0217 >

Related Discussions:

Dimethicone
can i have his copy?...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.